Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia
Authors
- Jingjing Yang (ORCID: https://orcid.org/0000-0001-8521-7492)
- Xiawei Zhang (ORCID: https://orcid.org/0000-0003-4070-9228)
- Sai Huang (ORCID: https://orcid.org/0000-0003-0823-1412)
- Liping Dou (ORCID: https://orcid.org/0000-0001-7352-9560)
- Lingmin Xu
- Meng Li (ORCID: https://orcid.org/0000-0002-8537-7872)
- Qingyang Liu (ORCID: https://orcid.org/0000-0003-3193-5856)
- Jing Yu (ORCID: https://orcid.org/0000-0003-4372-1353)
- Lei Lv
Institutions
- Chinese PLA General Hospital (CN)
- PLA Academy of Military Science (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.3389/fimmu.2025.1525110
- Citations
- 1
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.77